Private Trust Company’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Private Trust Company’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-4	Closed	-$1K	–	1262
2014 Q3	$1K	Sell	4 -4	-50%	-$1.02K	﹤0.01%	1814
2014 Q2	$2K	Buy	8 +3	+60%	+$791	﹤0.01%	1631
2014 Q1	$2K	Buy	+5	New	+$1.69K	﹤0.01%	1518

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Private Trust Company's ICPT Position: Q4 2014 in Review

Private Trust Company sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2014, closing a stake of 4 shares — an estimated $1K sold.

Private Trust Company first reported a position in ICPT in Q1 2014 and held it in 3 quarters. The position peaked at $2K in Q2 2014. 169 funds tracked by Wall St. Rank hold ICPT as of Q4 2014.

Private Trust Company reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2014 after selling out during the quarter.
Private Trust Company sold 4 Intercept Pharmaceuticals, Inc. shares in Q4 2014, an estimated $1K.
Private Trust Company first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2014 and held it in 3 quarters.
Private Trust Company's Intercept Pharmaceuticals, Inc. position peaked at $2K in Q2 2014.
169 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2014.

Based on Private Trust Company's 13F filing for Q4 2014, filed 28 Jan 2015.